Showing results (51-60 of 175) with videos related to
Sort By:
Pageof 18
Contemporary Clinical Trials Communications|August 3, 2019
Developing a model to predict accrual to cancer clinical trials: Data from an NCI designated cancer centerPraveena Iruku, Martin Goros, Jonathan Gelfond, et al.Leukemia & Lymphoma|October 7, 2022
Patient-reported outcomes of patients with myelofibrosis or essential thrombocythemia enrolled in the MOST studyEllen Ritchie, Anas Al-Janadi, Craig Kessler, et al.Plos One|April 6, 2023
Childhood cancer survival in the highly vulnerable population of South Texas: A cohort studyShenghui Wu, Yanning Liu, Melanie Williams, et al.Annals of Hematology|October 14, 2016
Management of extreme thrombocytosis in myeloproliferative neoplasms: an international physician surveyMaya Koren-Michowitz, Noa Lavi, Martin H Ellis, et al.Leukemia Research|August 27, 2017
Ruxolitinib for the management of myelofibrosis: Results of an international physician surveyMartin H Ellis, Maya Koren-Michowitz, Noa Lavi, et al.Journal of Hematology|November 22, 2021
Validation of a Modified Version of the Myeloproliferative Neoplasm Symptom Assessment Form Total Symptom ScoreBlake T Langlais, Gina L Mazza, Heidi E Kosiorek, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 7, 2018
Patient Perspectives Regarding Allogeneic Bone Marrow Transplantation in MyelofibrosisJeanne Palmer, Robyn Scherber, Marlene Girardo, et al.Plos One|May 9, 2024
Correction: Childhood cancer survival in the highly vulnerable population of South Texas: A cohort studyShenghui Wu, Yanning Liu, Melanie Williams, et al.JMIR Formative Research|April 30, 2019
Smartphone-Based Meditation for Myeloproliferative Neoplasm Patients: Feasibility Study to Inform Future TrialsJennifer Huberty, Ryan Eckert, Linda Larkey, et al.American Journal of Hematology|November 15, 2011
Long-term outcome of pomalidomide therapy in myelofibrosisKebede H Begna, Animesh Pardanani, Ruben Mesa, et al.Pageof 18